Physician

Alexander Robert Peck, DO

According to 2025 Medicare claims, Alexander Peck, DO (NPI: 1588197545) practices rheumatology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is PACIFIC ARTHRITIS CARE CENTER INC. (NPI: 1205862752; TIN: 743040915) and primary practice location at 90045-6279. Peck is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Peck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 503 traditional Medicare patients, billed 113,985 HCPCS/CPT codes, and received $1,609,767 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 861 prescription claims across 177 beneficiaries totaling $370,740 in drug costs, led by Teriparatide (Teriparatide). Open Payments data shows 115 records totaling $3,468. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,191 to $370,740. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$805K$1.6M2022 Medicare payment: $106,520 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $991,410 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,609,767 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022717,995$106,520
202327961,953$991,410
2024503113,985$1,609,767

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$185K$371K2017 Drug cost: $4,191 (USD; Tot_Drug_Cst)2018 Drug cost: $3,225 (USD; Tot_Drug_Cst)2019 Drug cost: $9,615 (USD; Tot_Drug_Cst)2020 Drug cost: $28,922 (USD; Tot_Drug_Cst)2021 Drug cost: $156,061 (USD; Tot_Drug_Cst)2022 Drug cost: $37,486 (USD; Tot_Drug_Cst)2023 Drug cost: $197,408 (USD; Tot_Drug_Cst)2024 Drug cost: $370,740 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R21$4,191
20182456$3,225
20192370$9,615
20201344$28,922
202130142$156,061
202250166$37,486
202399421$197,408
2024177861$370,740

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more154154$134
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more293539$100
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle251436$61
J0897Injection, denosumab, 1 mg23517,280$21
36415Insertion of needle into vein for collection of blood sample131212$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TeriparatideTeriparatide11308$21,850
MethotrexateMethotrexate Sodium1327,937$4,177
LeflunomideLeflunomide483,150$3,862
Hydroxychloroquine SulfateHydroxychloroquine Sulfate724,225$1,938
CelecoxibCelecoxib391,513$1,295

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.115$3,468Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Robert Peck, DO?

Tedicare shows public-source Medicare data for Alexander Robert Peck, DO (NPI 1588197545), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Robert Peck, DO have ACO affiliation data?

Alexander Robert Peck, DO is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Alexander Robert Peck, DO?

Alexander Robert Peck, DO is linked to PACIFIC ARTHRITIS CARE CENTER INC. (billing NPI 1205862752) in the available physician profile data.

Does Alexander Robert Peck, DO have Open Payments data?

Alexander Robert Peck, DO has 115 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.